A phase II, multi-center, randomized, double-blind, placebo-controlled trial of VLTS-934 in subjects with intermittent claudication secondary to peripheral arterial disease

被引:0
|
作者
Grossman, Paul M.
Fried, David
Rankin, Bruce
Martinez, Jeffrey
Gilderman, Larry
Weiss, Robert
Tonkon, Melvin
Hampsey, James
Glickman, Marc
Awan, Naajm
Dall'Olmo, Carlo
Kenton, David
Lilly, Michael
Moursi, Mohammed
Rask, Patrick
Anderson, R. David
Berberabe, Emilio
Corder, Clinton
Dadourian, Berger
Halpern, Stephen
Koren, Michael
Snell, Jeffery
机构
[1] Univ Michigan Hlth Syst, Ann Arbor, MI 21201 USA
[2] Omega Med Rsch, Warwick, RI USA
[3] Univ Clin Rsch Deland, Deland, FL USA
[4] Pro Rsch Grp, San Antonio, TX USA
[5] Univ Clin Rsch, Pembroke Pines, FL USA
[6] Androscoggin Cardiol Associates, Auburn, ME USA
[7] Apex Res Inst, Santa Ana, CA USA
[8] Tampa Bay Med Rsch, Clearwater, FL USA
[9] Vasc & Transplant Associates, Norfolk, VA USA
[10] Global CINRG Inc, Sacramento Med Rsch Ctr, Sacramento, CA USA
[11] Michigan Vasc Rsch Ctr, Flint, MI USA
[12] Deerfield Beach Cardiol Associates, Deerfield Beach, FL USA
[13] Univ Maryland, Med Ctr, Baltimore, MD USA
[14] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA
[15] New Hope Rsch Oregon, Portland, OR USA
[16] Sarasota Mem Hlth Care Syst, Clin Res Ctr, Sarasota, FL USA
[17] Access MedRsch LLC, Las Vegas, NV USA
[18] COR Clin Rsch, Oklahoma City, OK USA
[19] Lovelace Sci Resources Inc, Las Vegas, NV USA
[20] Radiant Rsch, Santa Rosa, CA USA
[21] Jacksonville Cntr Clin Rsch, Jacksonville, FL USA
[22] Rush Presbyterian St Lukes Med Ctr, Chicago, IL USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页码:2427 / 2427
页数:1
相关论文
共 50 条
  • [1] Day 180 results from a phase II multi-center, double blind placebo controlled study of VLTS-589 for intermittent claudication in subjects with peripheral arterial disease
    Grossman, PM
    Mendelsohn, F
    Henry, TD
    Hermiller, JB
    Litt, M
    Saucedo, J
    Weiss, RJ
    Kandzari, DE
    Kleiman, N
    Anderson, RD
    Gottlieb, D
    Karlsberg, R
    Dohad, S
    Snell, J
    Rocha-Singh, K
    CIRCULATION, 2005, 112 (17) : U472 - U473
  • [2] Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease
    Grossman, Paul Michael
    Mendelsohn, Farrell
    Henry, Timothy D.
    Hermiller, James B.
    Litt, Marc
    Saucedo, Jorge F.
    Weiss, Robert J.
    Kandzari, David E.
    Kleiman, Neal
    Anderson, R. David
    Gottlieb, Daniel
    Karlsberg, Ronald
    Snell, Jeffery
    Rocha-Singh, Krishna
    AMERICAN HEART JOURNAL, 2007, 153 (05) : 874 - 880
  • [3] Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease
    Rajagopalan, S
    Olin, JW
    Young, S
    Erikson, M
    Grossman, PM
    Mendelsohn, FO
    Regensteiner, JG
    Hiatt, WR
    Annex, BH
    HUMAN GENE THERAPY, 2004, 15 (06) : 619 - 624
  • [4] RANDOMIZED PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL OF KETANSERIN IN TREATMENT OF INTERMITTENT CLAUDICATION
    WALDEN, R
    BASS, A
    RABI, I
    ADAR, R
    JOURNAL OF CARDIOVASCULAR SURGERY, 1991, 32 (06): : 737 - 740
  • [5] DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF BUFLOMEDIL IN INTERMITTENT CLAUDICATION
    FONSECA, V
    MIKHAILIDIS, DP
    BARRADAS, MA
    JEREMY, JY
    GRACEY, L
    DANDONA, P
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1988, 8 (05) : 377 - 381
  • [6] PLACEBO-CONTROLLED, DOUBLE-BLIND, 2-CENTER TRIAL OF KETANSERIN IN INTERMITTENT CLAUDICATION
    BOUNAMEAUX, H
    HELLEMANS, H
    HOLDITCH, T
    BERENT, A
    VERHAEGHE, R
    LANCET, 1985, 2 (8467): : 1268 - 1271
  • [7] PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL OF KETANSERIN IN TREATMENT OF INTERMITTENT CLAUDICATION
    DECREE, J
    GEUKENS, H
    LEEMPOELS, J
    VERHAEGEN, H
    LANCET, 1984, 2 (8406): : 775 - 779
  • [8] A phase II multicenter, randomized, double-blind, placebo-controlled trial of plasmid Del-1 (developmentally regulated endothelial locus 1) in subjects with intermittent claudication secondary to peripheral arterial disease: DELTA1-PAD
    Rajagopalan, S
    Olin, J
    Mendelsohn, F
    Grossman, P
    Hermiller, J
    Sobolak, L
    Erikson, M
    Young, SW
    CIRCULATION, 2004, 110 (17) : 521 - 521
  • [9] Chinese Herbs For Acute Asthma: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial
    Wang, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [10] IncobotulinumtoxinA for the Treatment of Blepharospasm in Toxin-Naive Subjects: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial
    Mitsikostas, Dimos D.
    Dekundy, Andrzej
    Sternberg, Kati
    Althaus, Michael
    Pagan, Fernando
    ADVANCES IN THERAPY, 2020, 37 (10) : 4249 - 4265